Fisher Asset Management, LLC - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$330,000
-70.2%
46,245
-0.2%
0.00%
-100.0%
Q4 2019$1,106,000
-53.7%
46,328
-48.0%
0.00%
-66.7%
Q3 2019$2,389,000
-12.6%
89,067
-11.6%
0.00%0.0%
Q2 2019$2,733,000
-43.4%
100,722
-44.1%
0.00%0.0%
Q1 2019$4,827,000
+163.9%
180,076
+92.2%
0.00%
+50.0%
Q4 2018$1,829,000
-26.7%
93,6920.0%0.00%
-33.3%
Q3 2018$2,495,000
-28.1%
93,692
+2.0%
0.00%
-40.0%
Q2 2018$3,469,000
+9.9%
91,844
-5.0%
0.01%
+25.0%
Q1 2018$3,157,000
-32.9%
96,6540.0%0.00%
-33.3%
Q4 2017$4,705,000
+40.7%
96,654
+56.2%
0.01%
+20.0%
Q3 2017$3,344,000
+27.6%
61,893
+32.7%
0.01%
+25.0%
Q2 2017$2,620,000
+43.3%
46,6370.0%0.00%
+33.3%
Q1 2017$1,828,000
+74.6%
46,6370.0%0.00%
+50.0%
Q4 2016$1,047,000
-44.3%
46,637
-43.6%
0.00%
-33.3%
Q3 2016$1,879,000
-4.7%
82,7370.0%0.00%
-25.0%
Q2 2016$1,971,000
+2.3%
82,737
+3.0%
0.00%0.0%
Q1 2016$1,926,000
-53.4%
80,3000.0%0.00%
-50.0%
Q4 2015$4,131,000
+20.7%
80,3000.0%0.01%
+14.3%
Q3 2015$3,422,000
-6.5%
80,3000.0%0.01%0.0%
Q2 2015$3,658,000
+20.0%
80,3000.0%0.01%
+16.7%
Q1 2015$3,048,00080,3000.01%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 228,873$7,475,0004.17%
PFM Health Sciences, LP 5,326,671$173,969,0003.54%
Marcus Capital, LLC 22,950$750,0002.76%
Partner Investment Management, L.P. 72,284$2,361,0002.55%
CADIAN CAPITAL MANAGEMENT, LP 1,240,944$40,529,0002.19%
HARVEY CAPITAL MANAGEMENT INC 158,580$5,179,0001.94%
SECTORAL ASSET MANAGEMENT INC 498,412$16,278,0001.78%
Everett Capital Advisors UK LLP 551,173$18,001,0001.52%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 125,210$4,089,0001.46%
Atika Capital Management LLC 113,000$3,691,0001.26%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders